Cognitive Rehabilitation Program for Intellectual Disability
Trial Summary
What is the purpose of this trial?
This trial tests a special program with fun games on tablets to help children with mild intellectual disabilities improve their thinking skills. The program aims to make their brains work better through consistent game play.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment D-kit/EF1 for intellectual disability?
Is the Cognitive Rehabilitation Program for Intellectual Disability, also known as D-kit/EF1, safe for humans?
The available research highlights the importance of monitoring medication side effects in individuals with intellectual disability, as they are at higher risk for adverse effects due to complex healthcare needs and polypharmacy (use of multiple medications). While specific safety data for D-kit/EF1 is not provided, the general recommendation is to use medications cautiously, with regular monitoring to manage potential side effects.678910
How is the D-kit/EF1 treatment for intellectual disability different from other treatments?
Research Team
Young Shin Kim, MD PhD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for children aged 4-8 with borderline intellectual functioning or mild intellectual disability. They must be able to communicate and participate in tests and activities, and their legal guardians must consent. Children who can't see, hear well, or have been in another drug trial recently can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the D-kit/EF1 program or watch educational videos 5 times a week for 30 minutes each session
Follow-up
Participants are monitored for changes in executive function and cognitive improvement
Treatment Details
Interventions
- D-kit/EF1
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
DoBrain Inc.
Industry Sponsor